Participated · Series B · Feb 2026

Founded in 2024 and based in San Francisco, Bedrock Robotics is building system-level autonomy for the construction industry by upgrading excavators, bulldozers, loaders and other heavy equipment with advanced vision and control software. Its flagship Bedrock Operator platform allows contractors to manage connected fleets that run longer, reduce idle time, and improve safety while addressing the sector’s acute labor shortage. After emerging from stealth in July 2025, the company completed a large-scale supervised autonomy deployment on a 130-acre manufacturing site and is now piloting with contractors across port infrastructure, industrial facilities, data centers and earth-moving projects. Bedrock plans to launch its first fully operator-less excavator deployments in 2026, marking a significant leap toward fully autonomous job sites. The firm recently strengthened its leadership team with executives from Meta’s AI safety group and Waymo’s engineering organization. Its rapid execution and capital efficiency have attracted top-tier investors and pushed its valuation to $1.75 billion. To date, Bedrock has secured more than $350 million in total funding to accelerate product development and large-scale roll-outs.

Participated · Series A · Dec 2025

Excelsior Sciences is building a new form of machine-executable chemistry in which modular, synthesis-friendly “smart bloccs” enable rapid iterative carbon-carbon bond construction that AI can readily design, make and test in closed-loop workflows. This approach aims to shorten drug-discovery timelines, seamlessly bridge discovery and scale-up chemistry, and support the reshoring of pharmaceutical manufacturing to the United States. The company’s platform produces purified compounds fast enough to feed data-hungry algorithms, promising breakthroughs not only in therapeutics but also in materials science and other sectors. Spun out of Deerfield Management and operating from custom laboratory space at Cure in New York City, Excelsior couples proven automated synthesis expertise with advanced AI to generate rich datasets and novel molecular insights. Future plans include expanding its internal small-molecule pipeline and forging partnerships across multiple industries to commercialize the technology. To fund these initiatives the company secured $95 million in new capital, consisting of a $70 million Series A equity round and a $25 million grant.

Led · Equity · Oct 2025

Medi Assist Healthcare Services operates as an insurtech platform that helps insurers, corporates, and members manage health benefits through AI-enabled digital tools. The company positions itself at the forefront of India’s digital health transformation, offering technology that streamlines claims processing and health-benefit administration. Recent strategic activities include the acquisition of Fairfax-owned Paramount Health Services and a collaboration with Star Health Insurance, moves intended to deepen its service portfolio and market reach. Financially, Medi Assist just strengthened its balance sheet with a ₹198 crore equity infusion, lifting paid-up capital from ₹35.32 crore to ₹37.18 crore and expanding outstanding shares to 7.44 crore. Management highlights this capital as fuel for accelerated product innovation in AI-led solutions and further expansion across India’s healthcare ecosystem. The strong shareholder approval rate of 99.15 percent for the raise underscores investor confidence in the company’s growth trajectory.

Participated · Series A · Oct 2025

Cypher Games develops casual mobile games that blend traditional match-3 mechanics with dice-based luck elements and social, city-building metagames. Its first title, Match Squad, is nearing a U.S. launch and is reported to deliver strong early player engagement and best-in-class early- to mid-term retention. The company emphasizes rapid production cycles, premium art, and storytelling, and it is actively hiring additional talent in Turkey to scale development. Proceeds from recent funding will finalize Match Squad’s launch and kick-start creative work on a second game within two years. Founded by CEO Anil Simsek, Cypher has assembled backing from prominent industry veterans, including leaders from Discord, King, and Tripledot. Financially, the studio has secured $40 million to date—$10 million in seed financing completed in September 2024 and a new $30 million Series A. This capital base provides runway for product launches, talent expansion, and continued innovation in the casual mobile genre.

Participated · Series B · Sep 2025

Ketryx is an AI-native compliance platform that automates validation, traceability, and regulatory workflows across the life sciences product development lifecycle. The platform produces FDA/EU MDR-ready documentation and overlays existing tools to automate documentation without disrupting workflows. Customers include three of the top five global medtech companies, several Fortune 500 organizations, and AI-driven firms such as DeepHealth, Heartflow, and Aignostics. Users report up to a 90% reduction in documentation time and over 10x faster release cycles. With the new funding, Ketryx plans to continue global expansion, accelerate its product roadmap, and hire rapidly in Boston and Austria. The company positions itself as an enterprise-grade AI infrastructure layer that helps regulated teams balance safety, compliance, and faster innovation. Ketryx builds connected application lifecycle management software aimed at companies creating FDA‑regulated software and AI‑based applications in the life sciences. Its platform overlays product development tools to create a real‑time, traceable single solution that connects items, risks, code, and tests. The system automates documentation and enforces standard operating procedures across connected systems to improve quality and compliance. By linking development artifacts and processes, Ketryx aims to reduce time to market for regulated applications. The company is led by Founder and CEO Erez Kaminski and plans to use new funding to accelerate product development and commercial expansion.